Carson Wealth (CWM LLC)
BBIO icon

Carson Wealth (CWM LLC)’s BridgeBio Pharma BBIO Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$482K Buy
6,493
+49
+0.8% +$3.55K ﹤0.01% 2044
2025
Q4 		$493K Buy
6,444
+265
+4% +$17.4K ﹤0.01% 1929
2025
Q3 		$321K Sell
6,179
-651
-10% -$31.8K ﹤0.01% 2072
2025
Q2 		$295K Buy
6,830
+1,569
+30% +$57.1K ﹤0.01% 1881
2025
Q1 		$182K Buy
5,261
+598
+13% +$20.2K ﹤0.01% 1983
2024
Q4 		$128K Buy
4,663
+1,221
+35% +$31.6K ﹤0.01% 2116
2024
Q3 		$88K Buy
3,442
+1,964
+133% +$51.6K ﹤0.01% 2281
2024
Q2 		$37K Buy
1,478
+313
+27% +$8.56K ﹤0.01% 2667
2024
Q1 		$36K Buy
1,165
+348
+43% +$11.8K ﹤0.01% 2511
2023
Q4 		$33K Buy
817
+6
+0.7% +$180 ﹤0.01% 2428
2023
Q3 		$21K Hold
811
– – ﹤0.01% 2638
2023
Q2 		$14K Hold
811
– – ﹤0.01% 2855
2023
Q1 		$13K Buy
811
+277
+52% +$3.23K ﹤0.01% 2776
2022
Q4 		$4K Buy
534
+374
+234% +$3.58K ﹤0.01% 3263
2022
Q3 		$2K Hold
160
– – ﹤0.01% 3418
2022
Q2 		$1K Sell
160
-46
-22% -$385 ﹤0.01% 3491
2022
Q1 		$2K Buy
206
+191
+1,273% +$1.96K ﹤0.01% 3133
2021
Q4 		$0 Buy
+15
New +$635 ﹤0.01% 3488

Other funds holding BBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Carson Wealth (CWM LLC)'s BBIO Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its BridgeBio Pharma (BBIO) stake by 0.76% in Q1 2026, buying an estimated $3.55K and bringing the position to 6,493 shares worth $482K. The position accounts for ﹤0.01% of the portfolio, ranked #2044.

Carson Wealth (CWM LLC) first reported a position in BBIO in Q4 2021 and has held it in 18 quarters since. The position peaked at $493K in Q4 2025. 460 funds tracked by Wall St. Rank hold BBIO as of Q1 2026.

  • Carson Wealth (CWM LLC) held 6,493 shares of BridgeBio Pharma worth $482K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 49 BridgeBio Pharma shares in Q1 2026, an estimated $3.55K.
  • BridgeBio Pharma made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2044 holding.
  • Carson Wealth (CWM LLC) first reported a position in BridgeBio Pharma in Q4 2021 and has held it in 18 quarters since.
  • Carson Wealth (CWM LLC)'s BridgeBio Pharma position peaked at $493K in Q4 2025.
  • 460 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.